BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15518285)

  • 1. [Recombinant factor VII-a--new possibility for the treatment of severe postpartal bleeding--literature review].
    Katsulov A; Getskovski T; Iankov M; Kirova N
    Akush Ginekol (Sofiia); 2004; 43(5):44-6. PubMed ID: 15518285
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C; LucĂ­a JF
    Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of recombinant factor VIIa in severe postpartum hemorrhage.
    Segal S; Shemesh IY; Blumental R; Yoffe B; Laufer N; Mankuta D; Mazor M; Zohar S; Schiff E; Martinovitz U
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):771-2. PubMed ID: 15255852
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
    Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
    Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-partum hemorrhage: new therapeutic options].
    Franchini M
    Recenti Prog Med; 2007 Jan; 98(1):7-11. PubMed ID: 17345873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
    Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G
    Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
    Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
    Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
    Pekhlivanov B; Milchev N; Abrashev B
    Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
    Pepas LP; Arif-Adib M; Kadir RA
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose recombinant activated factor VII temporally stopped bleeding from small artery in severe postpartum hemorrhage: a case report.
    Ogawa M; Akahira S; Takahashi S; Shimoda Y; Sato M; Sato A; Terada Y
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):344-6. PubMed ID: 23448730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage.
    Searle E; Pavord S; Alfirevic Z
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1075-88. PubMed ID: 18838340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for use of recombinant factor VIIa in life-threatening post-partum haemorrhage.
    Duffy MR
    Int J Obstet Anesth; 2007 Jul; 16(3):299-300; author reply 300. PubMed ID: 17509865
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
    Franchini M; Lippi G; Franchi M
    BJOG; 2007 Jan; 114(1):8-15. PubMed ID: 17233855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
    Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
    Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant activated FVII in postpartum hemorrhage.
    Franchini M; Franchi M; Bergamini V; Montagnana M; Salvagno GL; Targher G; Lippi G
    Clin Obstet Gynecol; 2010 Mar; 53(1):219-27. PubMed ID: 20142658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
    Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
    J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of recombinant activated factor VII in obstetric hemorrhage.
    Ahonen J
    Curr Opin Anaesthesiol; 2012 Jun; 25(3):309-14. PubMed ID: 22473215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
    Gidiri M; Noble W; Rafique Z; Patil K; Lindow SW
    J Obstet Gynaecol; 2004 Nov; 24(8):925-6. PubMed ID: 16147656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.